Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2017-09-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and tolerance of generic travoprost with
its brand name formulation. In this open label, randomized, crossover study, the primary
outcome will be intraocular pressure and the secondary outcome will be tolerance to the
drops, as measured by a subjective questionnaire. Patients will be randomized to receive
either brand name or generic travoprost during the first visit. At the second visit 3 weeks
later, their intraocular pressure will be measured and a questionnaire will be completed on
the tolerance of the medication. Patients will then receive the other formulation of
travoprost. At the third and final visit, another 3 weeks later, their intraocular pressure
will be measured and a questionnaire will be completed on the tolerance of the second
medication.